Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.

Women's health (London, England) - 1 Sept 2009

Safra Tamar

Abstract excerpt

Recent evidence has indicated that the prognosis of women with epithelial ovarian cancer who are BRCA-mutation carriers may be better than for noncarriers. Part of the explanation is a higher sensitivity to platinum and other chemotherapies, as was demonstrated in in vitro studies, as well as a possible different biology. BRCA genes are important in double-strand DNA break repair and in other important processes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Diphosphate Ribose
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Ovarian Neoplasms

Share to Prognosis

Share to Risk Factors

Share to United States

Source

Identifiers

PMID: 19702453
DOI: 10.2217/whe.09.40

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.PMID 19702453Read ↗

Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies.Semantic proximity Read ↗

Hereditary breast and ovarian cancer: from genes to molecular targeted therapies.Semantic proximity Read ↗

BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis.Semantic proximity Read ↗

Hereditary ovarian cancer: not only BRCA 1 and 2 genes.Semantic proximity Read ↗

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.Semantic proximity Read ↗

The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future.Semantic proximity Read ↗

Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer.Semantic proximity Read ↗

[Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications].Semantic proximity Read ↗

BRCAness: Finding the Achilles Heel in Ovarian CancerSemantic proximity Read ↗

Hereditary ovarian cancer: beyond the usual suspects.Semantic proximity Read ↗

[Hereditary ovarian carcinomas: clinico-biological features and treatment].Semantic proximity Read ↗

Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.